109 related articles for article (PubMed ID: 17705055)
1. Poly(2-hydroxyethyl methacrylate) emboli with increased haemostatic effect for correction of haemorrhage of complex origin in endovascular surgery of children.
Horák D; Galibin IE; Adamyan AA; Sitnikov AV; Dan VN; Titova MI; Shafranov VV; Isakov YF; Gumargalieva KZ; Vinokurova TI
J Mater Sci Mater Med; 2008 Mar; 19(3):1265-74. PubMed ID: 17705055
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic activity of ethamsylate and aminocaproic acid adsorbed poly(2-hydroxyethyl methacrylate) particles.
Horák D; Svec F; Adamyan A; Titova M; Skuba N; Voronkova O; Trostenyuk N; Vishnevskii V; Gumargalieva K
Biomaterials; 1992; 13(8):521-6. PubMed ID: 1633225
[TBL] [Abstract][Full Text] [Related]
3. Poly(2-hydroxyethyl methacrylate) beads for the preoperative endovascular occlusion of branches of the hepatic artery in focal alterations of the liver.
Horak D; Svec F; Adamyan A; Titova M; Voronkova O; Trostenyuk N; Vishnevskii V; Guseinov E; Gumargalieva K
Clin Mater; 1990; 6(4):287-97. PubMed ID: 10147523
[TBL] [Abstract][Full Text] [Related]
4. Hydrogels in endovascular embolization. I. Spherical particles of poly(2-hydroxyethyl methacrylate) and their medico-biological properties.
Horák D; Svec F; Kálal J; Gumargalieva K; Adamyan A; Skuba N; Titova M; Trostenyuk N
Biomaterials; 1986 May; 7(3):188-92. PubMed ID: 3719036
[TBL] [Abstract][Full Text] [Related]
5. Hydrogels in endovascular embolization. II. Clinical use of spherical particles.
Horák D; Svec F; Kálal J; Adamyan AA; Volynskii YD; Voronkova OS; Kokov LS; Gumargalieva KZ
Biomaterials; 1986 Nov; 7(6):467-70. PubMed ID: 3790678
[TBL] [Abstract][Full Text] [Related]
6. Artificial emboli based on poly(2-hydroxyethyl methacrylate) particles in animal experiments.
Horák D; Jelínek F; Krajícková D
J Biomater Sci Polym Ed; 1999; 10(4):455-67. PubMed ID: 10227467
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E triggers poly(2-hydroxyethyl methacrylate) (PHEMA) embolic potential: a proposed application for endovascular surgery.
Renò F; Traina V; Gatti S; Cannas M
J Biomater Sci Polym Ed; 2011; 22(4-6):641-50. PubMed ID: 20566049
[TBL] [Abstract][Full Text] [Related]
8. Poly (2-hydroxyethyl methacrylate) particles for management of hemorrhage of complicated origin: treatment of hemobilia.
Horák D; Guseinov E; Adamyan A; Titova M; Danilov M; Trostenyuk N; Voronkova O; Gumargalieva K
J Biomed Mater Res; 1996; 33(3):193-7. PubMed ID: 8864891
[TBL] [Abstract][Full Text] [Related]
9. Hydrogels in endovascular embolization. VI. Toxicity tests of poly(2-hydroxyethyl methacrylate) particles on cell cultures.
Horák D; Cervinka M; Půza V
Biomaterials; 1997 Oct; 18(20):1355-9. PubMed ID: 9363335
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of radiopaque hydrogel microspheres based on PHEMA/iothalamic acid and PHEMA/iopanoic acid as particulate emboli.
Jayakrishnan A; Thanoo BC; Rathinam K; Mohanty M
J Biomed Mater Res; 1990 Aug; 24(8):993-1004. PubMed ID: 2394768
[TBL] [Abstract][Full Text] [Related]
11. Hydrogels in endovascular embolization. IV. Effect of radiopaque spherical particles on the living tissue.
Horák D; Svec F; Kálal J; Adamyan A; Skuba N; Titova M; Dan V; Varava B; Trostenyuk N; Voronkova O
Biomaterials; 1988 Jul; 9(4):367-71. PubMed ID: 3214662
[TBL] [Abstract][Full Text] [Related]
12. Poly(2-hydroxyethyl methacrylate) particles for preoperative endovascular occlusion of extensive angiodysplasias.
Horák D; Svec F; Adamyan AA; Titova MI; Dan VN; Trostenyuk NV; Voronkova OS; Gumargalieva KZ
J Appl Biomater; 1993; 4(3):253-9. PubMed ID: 10146309
[TBL] [Abstract][Full Text] [Related]
13. Use of poly(2-hydroxyethyl methacrylate) for endovascular occlusion in pediatric surgery.
Horák D; Svec F; Isakov Y; Polyaev Y; Adamyan A; Kostantinov K; Shafranov V; Voronkova O; Nikanorov A; Trostenyuk N
Clin Mater; 1992; 9(1):43-8. PubMed ID: 10149958
[TBL] [Abstract][Full Text] [Related]
14. Poly(HEMA)--based embolic material in endovascular surgery of liver.
Horák D; Sitnikov A; Guseinov E; Kokov L; Titova M; Adamyan A; Gumargalieva K
Polim Med; 2002; 32(3-4):48-62. PubMed ID: 12677651
[TBL] [Abstract][Full Text] [Related]
15. [Effect of renal artery embolization using 2-poly-hydroxyethyl-methacrylate as a liquid embolic agent: a study in rabbits].
Du H; Ma LT; Yin BL; Wu ZQ; Qin SZ; Xu GZ; Guo ZY; Zhang XY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):894-7. PubMed ID: 19460702
[TBL] [Abstract][Full Text] [Related]
16. Biodegradation of poly(2-hydroxyethyl methacrylate) (PHEMA) and poly{(2-hydroxyethyl methacrylate)-co-[poly(ethylene glycol) methyl ether methacrylate]} hydrogels containing peptide-based cross-linking agents.
Casadio YS; Brown DH; Chirila TV; Kraatz HB; Baker MV
Biomacromolecules; 2010 Nov; 11(11):2949-59. PubMed ID: 20961104
[TBL] [Abstract][Full Text] [Related]
17. Endovascular occlusion of branches of hepatic artery with poly(2-hydroxyethyl methacrylate) emboli as a single occlusive measure in hepatology.
Guseinov E; Horák D; Titova M; Adamyan A; Kokov L; Kubishkin V; Vishnevskii V; Skuba N; Trostenyuk N
Polim Med; 2000; 30(3-4):65-81. PubMed ID: 11288601
[No Abstract] [Full Text] [Related]
18. Hydrogels in endovascular embolization. V. Antitumour agent methotrexate-containing p(HEMA).
Horák D; Svec F; Adamyan A; Titova M; Skuba N; Voronkova O; Trostenyuk N; Vishnevskii V; Gumargalieva K
Biomaterials; 1992; 13(6):361-6. PubMed ID: 1610960
[TBL] [Abstract][Full Text] [Related]
19. [Morphological validation of the use of polyhydroxyethyl methacrylate-based x-ray contrast emboli for vascular occlusion].
Skuba ND; Adamian AA; Dan VN; Trosteniuk NV; Lopour P
Biull Eksp Biol Med; 1989 Mar; 107(3):379-82. PubMed ID: 2713484
[TBL] [Abstract][Full Text] [Related]
20. Biologically active thrombin-containing hydrogels based on poly(2-hydroxyethyl methacrylate) for endovascular occlusion.
Horák D; Svec F; Kálal J; Adamyan A; Titova M; Trostenyuk N; Skuba N; Dan V; Voronkova O; Gumargalieva K
Polim Med; 1991; 21(1-2):31-41. PubMed ID: 1815233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
